THOMAS MONATH to Cytomegalovirus
This is a "connection" page, showing publications THOMAS MONATH has written about Cytomegalovirus.
Connection Strength
0.044
-
A Randomized Dose-Escalating Phase I Trial of a Replication-Deficient Lymphocytic Choriomeningitis Virus Vector-Based Vaccine Against Human Cytomegalovirus. J Infect Dis. 2022 04 19; 225(8):1399-1410.
Score: 0.044